Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001381670 | SCV001580162 | pathogenic | Mevalonic aciduria; Porokeratosis 3, disseminated superficial actinic type; Hyperimmunoglobulin D with periodic fever | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 264 of the MVK protein (p.Leu264Phe). This variant is present in population databases (rs104895315, gnomAD 0.06%). This missense change has been observed in individual(s) with clinical features of mevalonate kinase deficiency and mevalonate kinase deficiency (PMID: 10417275, 11313768, 19786432, 22038276, 22566169, 29047407). ClinVar contains an entry for this variant (Variation ID: 97625). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MVK protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects MVK function (PMID: 10417275). For these reasons, this variant has been classified as Pathogenic. |
Unité médicale des maladies autoinflammatoires, |
RCV000083877 | SCV000115982 | not provided | Hyperimmunoglobulin D with periodic fever | no assertion provided | not provided |